XML 52 R36.htm IDEA: XBRL DOCUMENT
v3.19.2

Investments, Forward Contracts and Fair Value Measurements (Tables) | 12 Months Ended
--- | ---
Jun. 29, 2019
Investments and Fair Value Measurements [Abstract] |
Schedule of Available-for-sale Securities | The following table presents as of June 29, 2019, the Company’s available-for-sale securities (in millions):
| Amortized Cost/ Carrying Cost |  | Gross Unrealized Gains |  | Gross Unrealized Losses |  | Estimated Fair Value
Available-for-sale securities: |  |  |  |  |  |  |  |  |  |  |
Asset-backed securities | 0.9 |  |  | — |  |  | (0.3 | ) |  | 0.6 |
Total available-for-sale securities | $ | 0.9 |  |  | $ | — |  |  | $ | (0.3 | ) |  | $ | 0.6 |
As of June 30, 2018, the Company’s available-for-sale securities are as follows (in millions):
| Amortized Cost/ Carrying Cost |  | Gross Unrealized Gains |  | Gross Unrealized Losses |  | Estimated Fair Value
Debt securities: |  |  |  |  |  |  |  |  |  |  |
U.S. treasuries | $ | 36.0 |  |  | $ | — |  |  | $ | (0.1 | ) |  | $ | 35.9 |
U.S. agencies | 13.3 |  |  | — |  |  | (0.1 | ) |  | 13.2 |
Municipal bonds and sovereign debt instruments | 2.7 |  |  | — |  |  | — |  |  | 2.7 |
Asset-backed securities | 23.9 |  |  | — |  |  | (0.4 | ) |  | 23.5 |
Corporate securities | 114.9 |  |  | — |  |  | (0.6 | ) |  | 114.3 |
Total available-for-sale securities | $ | 190.8 |  |  | $ | — |  |  | $ | (1.2 | ) |  | $ | 189.6 |
Schedule of Gross Unrealized Losses on Available-for-sale Securities | As of June 29, 2019, the Company’s total gross unrealized losses on available-for-sale securities, aggregated by type of investment instrument, are as follows (in millions):
| Less than 12 Months |  | Greater than 12 Months |  | Total
Asset-backed securities | — |  |  | (0.3 | ) |  | (0.3 | )
Total gross unrealized losses | $ | — |  |  | $ | (0.3 | ) |  | $ | (0.3 | )
As of June 30, 2018, the Company’s total gross unrealized losses on available-for-sale securities, aggregated by investment type, are as follows (in millions):
| Less than 12 Months |  | Greater than 12 Months |  | Total
U.S. treasuries and agencies | $ | (0.1 | ) |  | $ | (0.1 | ) |  | $ | (0.2 | )
Asset-backed securities | (0.1 | ) |  | (0.3 | ) |  | (0.4 | )
Corporate securities | (0.4 | ) |  | (0.2 | ) |  | (0.6 | )
Total gross unrealized losses | $ | (0.6 | ) |  | $ | (0.6 | ) |  | $ | (1.2 | )
Schedule of Contractual Maturities of Available-for-sale Securities | As of June 29, 2019, the Company’s debt securities classified as available-for-sale securities with contractual maturities are as follows (in millions):
| Amortized Cost/Carrying Cost |  | Estimated Fair Value
Amounts maturing in less than 1 year | $ | — |  |  | $ | — |
Amounts maturing in 1 - 5 years | — |  |  | — |
Amounts maturing in more than 5 years | 0.9 |  |  | 0.6 |
Total debt available-for-sale securities | $ | 0.9 |  |  | $ | 0.6 |
Schedule of Assets Measured at Fair Value | The Company’s assets measured at fair value for the periods presented are as follows (in millions):
| June 29, 2019 |  | June 30, 2018
| Total |  | Level 1 |  | Level 2 |  | Level 3 |  | Total |  | Level 1 |  | Level 2 |  | Level 3
Assets: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Debt available-for-sale securities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
U.S. treasuries | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | 35.9 |  |  | $ | 35.9 |  |  | $ | — |  |  | $ | — |
U.S. agencies | — |  |  | — |  |  | — |  |  | — |  |  | 13.2 |  |  | — |  |  | 13.2 |  |  | — |
Municipal bonds and sovereign debt instruments | — |  |  | — |  |  | — |  |  | — |  |  | 2.7 |  |  | — |  |  | 2.7 |  |  | — |
Asset-backed securities | 0.6 |  |  | — |  |  | 0.6 |  |  | — |  |  | 23.5 |  |  | — |  |  | 23.5 |  |  | — |
Corporate securities | — |  |  | — |  |  | — |  |  | — |  |  | 114.3 |  |  | — |  |  | 114.3 |  |  | — |
Certificate of deposits | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
Total debt available-for-sale securities | 0.6 |  |  | — |  |  | 0.6 |  |  | — |  |  | 189.6 |  |  | 35.9 |  |  | 153.7 |  |  | — |
Marketable equity securities | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
Money market funds | 322.9 |  |  | 322.9 |  |  | — |  |  | — |  |  | 354.9 |  |  | 354.9 |  |  | — |  |  | — |
Trading securities | 1.5 |  |  | 1.5 |  |  | — |  |  | — |  |  | 1.6 |  |  | 1.6 |  |  | — |  |  | — |
Foreign currency forward contracts | 1.2 |  |  | — |  |  | 1.2 |  |  | — |  |  | 2.7 |  |  | — |  |  | 2.7 |  |  | — |
Total assets (1) | $ | 326.2 |  |  | $ | 324.4 |  |  | $ | 1.8 |  |  | $ | — |  |  | $ | 548.8 |  |  | $ | 392.4 |  |  | $ | 156.4 |  |  | $ | — |
Liability: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Foreign currency forward contracts (2) | $ | 4.0 |  |  | $ | — |  |  | $ | 4.0 |  |  | $ | — |  |  | $ | 11.7 |  |  | $ | — |  |  | $ | 11.7 |  |  | $ | — |
Contingent consideration (3) | 38.4 |  |  | — |  |  | — |  |  | 38.4 |  |  | — |  |  | — |  |  | — |  |  | — |
Total liabilities | $ | 42.4 |  |  | $ | — |  |  | $ | 4.0 |  |  | $ | 38.4 |  |  | $ | 11.7 |  |  | $ | — |  |  | $ | 11.7 |  |  | $ | — |
(1) | Includes as of June 29, 2019, $315.5 million in cash and cash equivalents, $1.5 million in short-term investments, $3.5 million in restricted cash, $1.2 million in other current assets, and $4.5 million in other non-current assets on the Company’s Consolidated Balance Sheets. Includes as of June 30, 2018, $364.8 million in cash and cash equivalents, $169.3 million in short-term investments, $7.3 million in restricted cash, $2.7 million in other current assets and $4.7 million in other non-current assets on the Company’s Consolidated Balance Sheets.
(2) | Includes $4.0 million and $11.7 million in other current liabilities on the Company’s Consolidated Balance Sheets as of June 29, 2019 and June 30, 2018, respectively.
(3) | Includes $37.7 million in other non-current liabilities and $0.7 million in other current liabilities as of June 29, 2019.
The Company’s Level 3 liabilities as of June 29, 2019, consist of contingent purchase consideration. The Company has aggregate contingent liabilities related to its business and asset acquisitions completed during fiscal 2019. The earn-out liabilities represent future payments by the Company of up to $63.0 million over four years, that are contingent on the achievement of certain revenue and gross profit targets. As June 29, 2019 the aggregate fair value of contingent consideration was $38.4 million. The fair value of earn-out liabilities were determined using a Monte Carlo Simulation that includes significant unobservable inputs such as the risk-free rate, risk-adjusted discount rate, the volatility of the underlying financial metrics and projected financial forecast of acquired business over the earn-out period. The fair value of contingent consideration liabilities is remeasured at each reporting period at the estimated fair value based on the inputs on the date of remeasurement, with the change in fair value recognized in the selling, general and administrative expense of the Consolidated Statements of Operations. The following table provides a reconciliation of changes in fair value of the Company’s Level 3 liabilities for the year ended June 29, 2019 (in millions):
| Contingent Consideration
Balance as of June 30, 2018 | $ | — |
Additions: To Level 3 contingent consideration liabilities | 44.3 |
Change: In fair value of contingent consideration liabilities | (5.9 | )
Balance as of June 29, 2019 | $ | 38.4 |

X
- Definition Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=99377789&loc=d3e19207-110258 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=99377789&loc=d3e19279-110258 + Details
Name: | us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments. + References No definition available. + Details
Name: | us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the reconciliation of available-for-sale securities from cost basis to fair value. + References No definition available. + Details
Name: | us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition For all investments in an unrealized loss position, including those for which other-than-temporary impairments have not been recognized in earnings (including investments for which a portion of an other-than-temporary impairment has been recognized in other comprehensive income), a tabular disclosure of the aggregate related fair value of investments with unrealized losses and the aggregate amount of unrealized losses (that is, the amount by which amortized cost basis exceeds fair value). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 320 -SubTopic 10 -Section 50 -Paragraph 6 -URI http://asc.fasb.org/extlink&oid=82897076&loc=d3e27290-111563 + Details
Name: | us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Investments and Fair Value Measurements [Abstract] + References No definition available. + Details
Name: | viav_InvestmentsandFairValueMeasurementsAbstract
Namespace Prefix: | viav_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration